| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0887-8994(97)00083-0 |
| P698 | PubMed publication ID | 9367297 |
| P2093 | author name string | Johnson A | |
| Connelly A | |||
| Ganesan V | |||
| Eckhardt S | |||
| Surtees RA | |||
| P2860 | cites work | Creatine deficiency in the brain: a new, treatable inborn error of metabolism | Q42280091 |
| Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism | Q48914906 | ||
| The use of automated electrospray ionization tandem MS for the diagnosis of inborn errors of metabolism from dried blood spots | Q71701308 | ||
| P433 | issue | 2 | |
| P921 | main subject | guanidinoacetate methyltransferase deficiency | Q5613758 |
| P304 | page(s) | 155-157 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Pediatric Neurology | Q15752159 |
| P1476 | title | Guanidinoacetate methyltransferase deficiency: new clinical features | |
| P478 | volume | 17 |
| Q31151655 | AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review |
| Q43645138 | Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry |
| Q24536125 | Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans |
| Q22241822 | Autism and Metabolic Diseases |
| Q73287554 | Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia |
| Q35188364 | Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism |
| Q37976595 | Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers |
| Q54276250 | Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. |
| Q28191709 | Creatine deficiency syndromes |
| Q28306965 | Creatine deficiency syndromes and the importance of creatine synthesis in the brain |
| Q28216730 | Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree |
| Q38727725 | Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models? |
| Q24811264 | Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. |
| Q46767187 | Effects in vitro of guanidinoacetate on adenine nucleotide hydrolysis and acetylcholinesterase activity in tissues from adult rats |
| Q31878568 | Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study |
| Q33864843 | Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity |
| Q48329441 | Global developmental delay in guanidionacetate methyltransferase deficiency: differences in formal testing and clinical observation |
| Q34094719 | Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia |
| Q73414509 | Guanidinoacetate methyltransferase (GAMT) deficiency: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism |
| Q51934047 | Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. |
| Q44963960 | Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle |
| Q34666769 | Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? |
| Q31028468 | In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders |
| Q21245421 | International Society of Sports Nutrition position stand: creatine supplementation and exercise |
| Q33791877 | International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine |
| Q33939183 | Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? |
| Q28191698 | Long-term creatine supplementation does not significantly affect clinical markers of health in athletes |
| Q44637712 | MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)‐deficient mice: Validation of an animal model to study creatine deficiency |
| Q37408409 | Neurometabolic disorders and dysfunction in autism spectrum disorders |
| Q73482726 | Plasma creatinine assessment in creatine deficiency: A diagnostic pitfall |
| Q33285975 | Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia |
| Q44612597 | S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects |
| Q34147667 | X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. |
| Q38208767 | X-linked creatine transporter deficiency: clinical aspects and pathophysiology |
Search more.